NDSU and Sanford Health are launching a research collaboration to evaluate factors that may affect the outcomes of next-generation GLP-1 obesity-management medications. The project is funded by a $210,000 investment from NDSU, Sanford Health and the North Dakota Department of Health and Human Services is designed to foster collaboration among research scientists with diverse expertise and backgrounds across both organizations.